CDC warns access to ADHD meds may be disrupted after arrests of health-care startup executives

People with ADHD may face challenges accessing treatment following the arrests of two executives at a telehealth company that distributed ADHD medications. The US CDC has issued a health advisory warning about potential disruptions to care. The US Department of Justice has indicted two executives from the company, who are accused of distributing medication illegally and committing health care fraud. The impact on patients is yet to be determined. The arrests are the first criminal drug distribution prosecutions related to telemedicine. The CDC advises patients to be cautious and seek medication only from licensed clinicians and pharmacies.